Collin Spencer is an associate at Catalio Capital Management focused on private investments in AI-enabled healthcare. He previously worked as an AI product engineer at Coefficient Bio, was a Schmidt Sciences fellow and co-founded Nucleate NYC.
Collin Spencer is an associate at Catalio Capital Management focused on private investments in AI-enabled healthcare. He previously worked as an AI product engineer at Coefficient Bio, was a Schmidt Sciences fellow and co-founded Nucleate NYC.
Career
Collin Spencer holds a PhD, Biomedical AI from Icahn School of Medicine at Mount Sinai and a BS, Computational Biology from Georgia Institute of Technology.
Associate at Catalio Capital Management until Present